Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00290004 · COMPLETED
Trial details
- NCT number
- NCT00290004
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2007-02-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.